Results 11 to 20 of about 999 (177)
The triglyceride–glucose index is a valuable marker of insulin resistance. However, the predictive value of this index for postoperative atrial fibrillation in patients undergoing septal myectomy remains unclear. A total of 409 patients with hypertrophic
Zhipeng Wei+5 more
doaj +1 more source
Background Although septal myectomy is a standard strategy for managing patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms, so far, only a few experienced myectomy centers exist globally.
Qiang Ji+6 more
doaj +1 more source
Transmitral Septal Myectomy [PDF]
In patients undergoing operative intervention for hypertrophic cardiomyopathy (HCM), intrinsic abnormalities of the mitral valve may need to be addressed at the time of septal myectomy. Advantages of a transmitral approach to septal myectomy include a panoramic view of the septum and the exposure necessary to address concomitant mitral valve pathology.
Brody Wehman, James S. Gammie
openaire +1 more source
Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy is a common genetic heart disease characterized predominantly by non-dilated hypertrophy of the left ventricle, in the absence of other cardiac, systemic, or metabolic diseases that can cause the observed degree of hypertrophy.
Sergei A. Budagaev+7 more
doaj +1 more source
Septal myectomy for obstructive hypertrophic cardiomyopathy [PDF]
Septal myectomy effectively relieves left ventricular outflow tract obstruction (LVOTO) and cardiac symptoms in both adults and children with obstructive hypertrophic cardiomyopathy (HCM). Abnormal attachments of the papillary muscles and chordae and other cardiac lesions can be repaired at the same time. Early mortality for isolated septal myectomy in
Joseph A. Dearani, Gordon K. Danielson
openaire +4 more sources
Transaortic septal myectomy: techniques and pitfalls [PDF]
Hypertrophic cardiomyopathy (HCM) is the most common congenital cardiac disease, affecting up to 1 in 200 individuals. When it causes left ventricular outflow tract (LVOT) obstruction, treatment is indicated to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first line treatment, however if it fails, surgical myectomy
Pietro Bajona+2 more
openaire +2 more sources
Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients?
Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority ...
Alexandru Achim+5 more
doaj +1 more source
Transaortic septal myectomy using direct septal echography [PDF]
We applied direct septal echography in transaortic septal myectomy for left ventricular outflow tract obstruction due to hypertrophic obstructive cardiomyopathy and asymmetric septal hypertrophy. A small L-shaped probe was inserted into the right ventricle through a 2-cm incision on the right ventricular outflow tract.
Masataka Sato+3 more
openaire +3 more sources
Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
Introduction and ObjectivesThe risk of ventricular arrhythmia and heart failure in patients with hypertrophic obstructive cardiomyopathy (HOCM) is much higher than that in the general population.
Xiangbin Meng+9 more
doaj +1 more source
Automated interpretation of congenital heart disease from multi-view echocardiograms [PDF]
Congenital heart disease (CHD) is the most common birth defect and the leading cause of neonate death in China. Clinical diagnosis can be based on the selected 2D key-frames from five views. Limited by the availability of multi-view data, most methods have to rely on the insufficient single view analysis.
arxiv +1 more source